A new five-day pill by Dova Pharmaceuticals won approval Monday. The pill is designed to temporarily build up platelet counts in patients with chronic liver disease so they can get a tooth pulled or a biopsy without risk of severe bleeding.
A new five-day pill by Dova Pharmaceuticals won approval Monday. The pill is designed to temporarily build up platelet counts in patients with chronic liver disease so they can get a tooth pulled or a biopsy without risk of severe bleeding. Dova Pharmaceuticals
A new five-day pill by Dova Pharmaceuticals won approval Monday. The pill is designed to temporarily build up platelet counts in patients with chronic liver disease so they can get a tooth pulled or a biopsy without risk of severe bleeding. Dova Pharmaceuticals

FDA approves drug to control life-threatening bleeding in patients with liver disease

May 21, 2018 05:33 PM